Gallacher Capital Management LLC Raises Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Gallacher Capital Management LLC boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 20.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,216 shares of the healthcare conglomerate’s stock after acquiring an additional 205 shares during the period. Gallacher Capital Management LLC’s holdings in UnitedHealth Group were worth $640,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. Richelieu Gestion SA purchased a new position in UnitedHealth Group in the fourth quarter worth about $26,000. CGC Financial Services LLC increased its holdings in UnitedHealth Group by 1,000.0% in the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 50 shares in the last quarter. NewSquare Capital LLC increased its stake in shares of UnitedHealth Group by 340.0% in the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after purchasing an additional 51 shares in the last quarter. LFA Lugano Financial Advisors SA boosted its holdings in UnitedHealth Group by 148.1% in the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after buying an additional 40 shares during the period. Finally, Annapolis Financial Services LLC raised its holdings in UnitedHealth Group by 38.6% during the third quarter. Annapolis Financial Services LLC now owns 79 shares of the healthcare conglomerate’s stock valued at $40,000 after acquiring an additional 22 shares during the period. Institutional investors own 87.86% of the company’s stock.

Insider Activity

In other news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have issued reports on UNH. Piper Sandler lifted their price target on shares of UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a report on Wednesday, April 17th. Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Stephens reissued an “overweight” rating and set a $605.00 target price on shares of UnitedHealth Group in a research report on Thursday, February 8th. Bank of America reiterated a “buy” rating and set a $675.00 price objective on shares of UnitedHealth Group in a research report on Thursday, March 7th. Finally, Oppenheimer reaffirmed an “outperform” rating and set a $610.00 target price on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Four investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average price target of $570.05.

UnitedHealth Group Stock Performance

Shares of NYSE UNH traded down $0.52 during midday trading on Friday, reaching $492.45. The company had a trading volume of 2,487,811 shares, compared to its average volume of 5,130,659. The stock has a market cap of $453.09 billion, a P/E ratio of 30.10, a P/E/G ratio of 1.43 and a beta of 0.55. The company has a current ratio of 0.85, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69. The business’s 50-day simple moving average is $482.32 and its 200 day simple moving average is $512.42. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $554.70.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating the consensus estimate of $6.63 by $0.28. The business had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business’s revenue for the quarter was up 8.6% on a year-over-year basis. During the same period in the prior year, the firm earned $6.26 EPS. On average, analysts forecast that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were given a $1.88 dividend. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.53%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 45.97%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.